학술논문

Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.
Document Type
Article
Source
Kidney International. Nov2004, Vol. 66 Issue 5, p1881-1889. 9p.
Subject
*PUROMYCIN
*AMINOGLYCOSIDES
*ANTINEOPLASTIC agents
*NEPHROTIC syndrome
*KIDNEY diseases
*SYNDROMES
Language
ISSN
0085-2538
Abstract
Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside.Background.An imbalance between the generation of reactive oxygen species (ROS) and antioxidant defense mechanisms has been suggested to play an important role in podocyte injury in nephrotic syndrome. Experimental nephrotic syndrome induced by injection of puromycin aminonucleoside (PAN) into rats is a well-established model of nephrotic syndrome, and can be largely prevented by pretreatment with antioxidant enzymes (AOE), suggesting that podocyte injury may be mediated by ROS.Methods.To test the hypothesis that PAN-induced podocyte injury is modulated in part by podocyte antioxidant defenses, we analyzed AOE activities, lipid peroxidation products, and relative ROS levels in podocytes using our recently reported in vitro model of PAN-induced podocyte injury.Results.PAN treatment induced early increases in both podocyte hydrogen peroxide and superoxide and later increases in lipid peroxidation products. Compared to baseline activities, PAN also induced significant changes in the major cellular AOE activities (maximum increases of 151% for catalase, 134% for superoxide dismutase, and 220% for glutathione peroxidase vs. time-matched controls). These changes largely preceded the development of extensive podocyte process retraction and actin filament disruption, which was maximal at 7 days.Conclusion.These results demonstrate that (1) PAN treatment induces significant early changes in podocyte ROS, (2) podocytes can mount an antioxidant defense against oxidant stress, and (3) this protective response is initiated prior to the development of extensive oxidant-induced podocyte structural injury. These findings suggest that enhancement of podocyte AOE activities represent a potential therapeutic target to protect from or ameliorate podocyte injury during nephrotic syndrome. [ABSTRACT FROM AUTHOR]